NCT01627470

Brief Summary

The aim of the study is to evaluate the accuracy of continuous non-invasive AP monitoring (CNAP) compared to simultaneous IBP measurement in intensive care patients undergoing a transport in the ambulance car. Since CNAP finger blood pressure is calibrated to NBP level, a systematic bias between IBP and CNAP as described by a recent FDA meta analysis \[ \] is expected. The most important factor of CNAP system performance is its ability to accurately track blood pressure changes. Thus, the purpose of this investigation is to show that the bias between CNAP and IBP falls within the expected range and that blood pressure alterations are detected instantaneously. The endpoints of the study are:

  • The agreement of systolic, diastolic and mean CNAP and IBP readings determined on a beat-to-beat basis during:
  • Takeover of the patient on the intensive care unit,
  • Transport of the patient from the intensive care unit to the ambulance car
  • Transport of the patient in the ambulance car
  • The agreement of systolic, diastolic and mean CNAP and IBP blood pres-sure changes determined on a beat-to-beat basis during:
  • Takeover of the patient on the intensive care unit,
  • Transport of the patient from the intensive care unit to the ambulance car
  • Transport of the patient in the ambulance car The beat-to-beat readings of CNAP and IBP will be automatically recorded electronically on a memory card in the transport monitor. CNAP data will additionally be recorded directly on the CNAP Monitor with a memory stick. Safety will be assessed by clinical observations as well as adverse events (AE) recording.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2011

Completed
8 months until next milestone

First Posted

Study publicly available on registry

June 25, 2012

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
Last Updated

June 25, 2012

Status Verified

June 1, 2012

Enrollment Period

1 year

First QC Date

November 2, 2011

Last Update Submit

June 22, 2012

Conditions

Keywords

non-invasive arterial pressureemergencyintensive care

Outcome Measures

Primary Outcomes (1)

  • agreement with invasive blood pressure

    beat-to-beat readings of CNAP and IBP

    1 year

Study Arms (1)

Cohort

Emergency Patients with applied arterial blood pressure measurement

Device: CNAP-Monitor

Interventions

Continuous non-invasive arterial blood pressure recording

Also known as: CNAP, Continuous non-invasive arterial blood pressure recording
Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ICU Patients with established arterial pressure measurement

You may qualify if:

  • Patients willing and capable of giving informed consent or with legal agents willing of giving informed consent
  • Patients undergoing a transport from the intensive care unit to another institution with the ambulance car
  • Patients where the IBP cannula was already placed on the intensive care unit
  • Patients where IBP cannula, and CNAP upper arm cuff can be placed on the same arm, and CNAP finger cuff can be placed on the contra-lateral arm
  • Intact perfusion of both arm evidenced by a negative Allen's test
  • Age 18 years and above
  • ASA I-IV
  • Weight \>= 40 and \<= 180 kg, BMI \< 35

You may not qualify if:

  • Patients with history of neurological, neuromuscular seizure
  • Patients where IBP cannula cannot be placed in the radial artery
  • Patients with vascular implants at the sites of non-invasive blood pressure measurement (fingers and upper arm)
  • Patients with history of arrhythmias
  • Edematous patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Schleswig-Holstein - Campus Kiel

Kiel, 24105, Germany

RECRUITING

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Robert Hanss, PD Dr.

    UKSH-Campus Kiel

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PD Dr. med.

Study Record Dates

First Submitted

November 2, 2011

First Posted

June 25, 2012

Study Start

August 1, 2011

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

June 25, 2012

Record last verified: 2012-06

Locations